Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
Stromedix, Inc.
ClinicalTrials.gov Identifier:
NCT00878761
First received: April 6, 2009
Last updated: May 20, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)